NCT06047015 2024-08-09
Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer
University of Saskatchewan
Phase 1/2 Not yet recruiting
Clinical Trials
6 trialsNCT04952272 2024-06-26
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Phase 1 Recruiting
NCT04995536 2024-04-25
CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL
City of Hope Medical Center
Phase 1 Withdrawn
NCT00640861 2018-10-31
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01035216 2014-12-23
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
SBI Biotech Co., Ltd.
Phase 1 Terminated
NCT00190424 2012-12-13
Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed